NEXGEL says Q3 revenue jumps almost 70%
“We expect to grow revenue in 2023 and margins to expand as we continue to scale while realizing the benefits from our fixed facility expense structure,” said CEO Adam Levy
Sector
1090 stories · page 32 of 55
“We expect to grow revenue in 2023 and margins to expand as we continue to scale while realizing the benefits from our fixed facility expense structure,” said CEO Adam Levy
NHS Nurses could embark on their first ever UK-wide strike over pay and conditions, with ballot results due to be announced on Wednesday
“We are positioned as one of the first household brands to have a national footprint in THC, and this partnership with Mockingbird Cannabis in Mississippi is a great step toward that goal,” Irwin Naturals CEO Klee Irwin said
Action on Smoking Health found that 81% of shopkeepers agree there should be tougher measures on tobacco sales.
"We're moving fast to realize our goal of being first in building the biggest chain of psychedelic mental healthcare clinics in the country,” said Klee Irwin, CEO of Irwin Naturals
“As we anticipate changes from Health Canada to allow for the sale of Cannabis Health Products in pharmacies, forward thinking chains are staking their position as the leaders in education, advice and safety for consumers researching medica
“This agreement generates additional value for Wellbeing shareholders and allows Wellbeing to focus on expanding our clinical network footprint to treat mental health indications with novel medicines in conjunction with digital therapeutics
The Supreme Court of British Columbia issued an interim order that authorizes a special meeting of Wellteq shareholders
NEXGEL's patches delivered an equivalent dose faster and are longer-acting compared to the current standard-of-care for short term pain treatment
The patch will be available to ophthalmologists and optometrists in first half of 2023
Through the HB Affordability Program, the services are now available for as little as $1 per day, for eligible Medicare enrolees for low to no costs through their providers and is supported by FSA/HSA eligibility
"Alberta's new regulations aim to set minimum standards for the safe administration of psychedelic-assisted psychotherapy," said Najla Guthrie, CEO of Wellbeing and KGK Sciences
“This is certainly an exciting time for KGK Science and our client as we finalize the clinical trial application that will be submitted to Health Canada for approval of a Phase 2A study evaluation psilocybin microdose therapy for fragile X
As Mental Illness Awareness Week kicked off October 2, KetaMD has ramped up operations, expanding session availability
“Having built a reputable practice across several locations in both San Diego and Las Vegas, these clinics will benefit from the company’s operational and administrative support and leading-edge clinical resources while maximizing value for
The clinic will join Irwin Naturals Emergence which already has deals to add 11 clinics across six different states
"While this transaction will contribute immediately to our profitability, this acquisition is driven predominantly by strategic considerations,” Irwin CEO Klee Irwin said
A letter to investors from chief executive Michael Schmainda revealed that revenue from annual subscription renewals from existing clients "continue to fuel our business"
"Our new research center will draw upon the strength and heritage of applied research and innovation and will be an ongoing opportunity for ground-breaking research in the fields of nutraceuticals, cannabinoids, hemp and psychedelics," said